Skip to main content
. 2023 Feb 9;9:e41404. doi: 10.2196/41404

Table 1.

Descriptive statistics related to the demographic and clinical characteristics of patients.

Variable and category Entire population (N=1,918,549), n (%) Access to the swab (n=85,348), n (%) Positivity to SARS-Cov-2 (n=12,793), n (%) Hospitalization (n=4644), n (%) Admitted to the ICUa (n=1508), n (%) Death within 30 days (n=749), n (%)
Gender

Male 938,610 (48.9) 32,129 (37.6) 5961 (46.6) 3075 (66.2) 1118 (74.1) 558 (74.5)
Female 979,939 (51.1) 53,219 (62.4) 6832 (53.4) 1569 (33.8) 390 (25.9) 191 (25.5)
Age (years)

45-59 1,062,861 (55.4) 54,672 (64.1) 7324 (57.2) 1717 (37.0) 503 (33.4) 120 (16.0)
60-74 855,688 (44.6) 30,676 (35.9) 5469 (42.8) 2927 (63.0) 1005 (66.6) 629 (84.0)
Month of first swab

February-March N/Ab 14,134 (16.6) 5364 (41.9) 3088 (66.5) 1079 (71.5) 502 (67.0)
April-May N/A 71,214 (83.4) 7429 (58.1) 1556 (33.5) 429 (28.5) 247 (33.0)
CCIc

0 1,442,666 (75.2) 58,775 (68.8) 8,620 (67.4) 2,599 (56.0) 837 (55.5) 280 (37.4)
1 335,685 (17.5) 16,180 (19.0) 2540 (19.8) 1091 (23.5) 361 (23.9) 175 (23.3)
2-3 121,723 (6.3) 8099 (9.5) 1277 (10.0) 710 (15.3) 233 (15.5) 199 (26.6)
4+ 18,475 (1.0) 2294 (2.7) 356 (2.8) 244 (5.2) 77 (5.1) 95 (12.7)
Oncological disease 58,742 (3.1) 3993 (4.7) 525 (4.1) 303 (6.5) 83 (5.5) 82 (11.0)
Cardiovascular disease 136,335 (7.1) 9239 (10.8) 1480 (11.6) 797 (17.2) 252 (16.7) 217 (29.0)
Respiratory disease 50,328 (2.6) 4792 (5.6) 751 (5.9) 426 (9.2) 124 (8.2) 129 (17.2)
Myocardial infarction 40,288 (2.1) 2416 (2.8) 420 (3.3) 278 (6.0) 99 (6.6) 78 (10.4)
Heart failure 7,817 (0.4) 762 (0.9) 117 (0.9) 79 (1.7) 22 (1.5) 28 (3.7)
Cerebrovascular disease 23,753 (1.2) 2197 (2.6) 378 (2.9) 186 (4.0) 53 (3.5) 72 (9.6)
Diabetes 157,214 (8.2) 8335 (9.8) 1547 (12.1) 896 (19.3) 352 (23.3) 239 (31.9)

aICU: intensive care unit.

bN/A: not applicable.

cCCI: Charlson Comorbidity Index.